Form 4: Zoetis CFO Joseph Wetteny Receives Equity Awards

Zoetis Inc.'s Chief Financial Officer, Joseph Wetteny, was granted restricted stock units and stock options as part of the company's equity incentive plan.

Summary

• Joseph Wetteny, Chief Financial Officer of Zoetis Inc. (ZTS), was granted various equity awards.
• Awards include Restricted Stock Units (RSUs) and Stock Options, issued under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
• On February 18, 2026, 8,605 RSUs were granted, vesting one-third annually on the first, second, and third anniversaries of the grant date.
• On February 19, 2025, 6,152.6517 RSUs were granted, vesting one-third annually on the first, second, and third anniversaries of the grant date.
• On February 6, 2024, 1,389 RSUs were granted, vesting one-third annually on the first, second, and third anniversaries of the grant date.
• On February 18, 2026, 34,045 stock options were granted with an exercise price of $129.13, vesting one-third annually on the first, second, and third anniversaries of the grant date.
• On February 19, 2025, 23,625 stock options were granted with an exercise price of $156.64, vesting one-third annually on the first, second, and third anniversaries of the grant date.
• On February 6, 2024, 15,625 stock options were granted with an exercise price of $196.14, vesting one-third annually on the first, second, and third anniversaries of the grant date.
• On February 8, 2023, 15,208 stock options were granted with an exercise price of $162.07, with one-third having vested on the first, second, and third anniversaries of the grant date.
• On February 8, 2022, 11,243 stock options were granted with an exercise price of $201.3, which vested on the third anniversary of the grant date.
• Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
• All stock options expire on the tenth anniversary of their respective grant dates.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive sign of continued executive alignment with shareholder interests through long-term equity incentives, which is a standard and healthy corporate governance practice.

Positives

• The granting of equity awards aligns the Chief Financial Officer's long-term interests with those of shareholders, incentivizing sustained company performance.
• The awards are part of a structured equity incentive plan, indicating a commitment to executive retention and motivation.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future financial performance or strategic direction beyond the vesting schedules of the equity awards.

Industry Context

StockSavvy.ai notes that equity compensation, including restricted stock units and stock options, is a standard practice across the pharmaceutical and animal health industries. These awards are designed to attract, retain, and motivate key executives by linking their compensation directly to the company's long-term stock performance and shareholder value creation.

Comparison to Industry Standards

• Equity compensation packages for CFOs in large-cap pharmaceutical or animal health companies like Zoetis are typically structured with a mix of RSUs and stock options, often vesting over several years to ensure long-term alignment.
• Companies such as Elanco Animal Health (ELAN) or Merck & Co. (MRK) also utilize similar long-term incentive plans for their executives, featuring multi-year vesting schedules for equity awards to foster sustained performance and executive retention.

Related Party Transactions

• The equity awards granted to Joseph Wetteny, the Chief Financial Officer, represent related party transactions between the company and an executive.

Stakeholder Impact

• Shareholders: The equity awards are designed to align the interests of the CFO with shareholders, potentially leading to improved long-term company performance and shareholder value.
• Employees: The compensation structure for key executives can influence overall employee morale and perception of fairness within the company's compensation philosophy.

Next Steps

• The granted Restricted Stock Units and Stock Options will vest according to their specified schedules, contingent on the reporting person's continued service.

Key Dates

Recommendation

The Form 4 details routine equity compensation grants to the Chief Financial Officer, which is a standard practice for executive incentive plans. This filing alone does not provide sufficient new information to alter an existing investment thesis for Zoetis Inc., thus a 'hold' recommendation is appropriate.

Keywords

Zoetis, ZTS, Form 4, insider transaction, equity award, RSU, stock option, executive compensation, Joseph Wetteny